Apr 25, 2019 / 12:00PM GMT
Operator
Ladies and gentlemen, thank you for standing by. Welcome to Bayer's Investor and Analyst Conference Call on the First Quarter 2019 Results. (Operator Instructions)
And I would now like to turn the conference over to Mr. Oliver Maier, Head of Investor Relations of Bayer. Please go ahead, sir.
O. Maier - Bayer Aktiengesellschaft - Head of IR
Emma, thank you very much. Good afternoon, and thanks, everybody, for joining us today. I'd like to welcome all of you for the first quarter 2019 conference call.
With me on the call today are our CEO, Werner Baumann; and our CFO, Wolfgang Nickl. And the businesses are represented by the responsible Management Board members, as we have Stefan Oelrich for Pharma; Heiko Schipper for Consumer Health; and Liam Condon for Crop Science.
Werner will begin today's call with an overview of the key developments and performance of the divisions. Wolfgang will then cover the financials for Q1 2019 and the outlook as well as the key focus areas for 2019 before we open up for the Q&A session. (Operator
Q1 2019 Bayer AG Earnings Call Transcript
Apr 25, 2019
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers